HolderBook

DIADEMA PARTNERS LP

Reported holdings as of Q2 2026, from 7 quarterly filings.

CIK
2026172
Reported value
$791.3M
Positions
116
Top 10 weight
50.4%
Filed
2026-08-14
Days after quarter end
45

Holdings

SecurityTickerValue SharesWeightWeight change Held Change
ABIVAX SA OPTABVX$101.8M163,64412.86%+7.67pp4q+115.5%+$54.5M
VIKING THERAPEUTICS INC OPTVKTX$78.5M441,8089.92%+3.37pp6q-15.9%-$14.8M
BRISTOL-MYERS SQUIBB CO OPTBMY$53.6Moptions only6.78%-newOPTIONS
UNITED THERAPEUTICS CORP DELUTHR$28.7M52,9893.63%-5.20pp3q+94.1%+$13.9M
REVOLUTION MEDICINES INCRVMD$26.1M139,2183.29%-0.12pp5q+72.1%+$10.9M
UNIQURE NV OPTQURE$24.6Moptions only3.11%+1.50pp7qOPTIONS
NOVARTIS AG OPTNVS$23.5Moptions only2.97%-newOPTIONS
KODIAK SCIENCES INC OPTKOD$21.9M218,1172.77%-0.09pp4q+13.0%+$2.5M
CAPRICOR THERAPEUTICS INC OPTCAPR$20.8Moptions only2.63%-2.71pp7qOPTIONS
COGENT BIOSCIENCES INCCOGT$19.1M493,6642.41%+0.30pp7q+52.9%+$6.6M
BRIDGEBIO PHARMA INC$18.6M250,0002.35%-0.81pp2qDEBT
CORCEPT THERAPEUTICS INC OPTCORT$17.9Moptions only2.27%+1.11pp6qOPTIONS
BIOMARIN PHARMACEUTICAL INCBMRN$17.9M312,8462.26%+0.84pp6q+111.1%+$9.4M
KYMERA THERAPEUTICS INC OPTKYMR$17.2Moptions only2.17%-newOPTIONS
SUMMIT THERAPEUTICS INC OPTSMMT$16.3M60,0002.06%-newNEW
HIMS & HERS HEALTH INC OPTHIMS$13.6Moptions only1.72%-newOPTIONS
REPLIMUNE GROUP INC OPTREPL$13.3Moptions only1.68%+0.68pp7qOPTIONS
BIOGEN INC OPTBIIB$13.0Moptions only1.64%-newOPTIONS
ELI LILLY & CO OPTLLY$12.0Moptions only1.52%+0.58pp6qOPTIONS
INCYTE CORP OPTINCY$11.9Moptions only1.51%-1.43pp4qOPTIONS
EDGEWISE THERAPEUTICS INCEWTX$11.1M272,2141.40%+0.26pp3qHELD
ARCUS BIOSCIENCES INC OPTRCUS$10.7M223,8101.36%+0.48pp2q-6.0%-$686.7K
BIONTECH SE OPTBNTX$9.3Moptions only1.18%-newOPTIONS
CORBUS PHARMACEUTICALS HLDGS OPTCRBP$8.8M301,2641.11%+0.22pp2q-31.5%-$4.0M
VAXCYTE INC OPTPCVX$8.5M45,0711.08%+0.31pp7q+79.8%+$3.8M
BIOAGE LABS INC OPTBIOA$8.5M146,3341.07%+0.89pp3q+143.9%+$5.0M
IMMUNOCORE HLDGS PLCIMCR$8.1M254,8631.02%+0.03pp6q+31.9%+$2.0M
4D MOLECULAR THERAPEUTICS INFDMT$7.6M571,1070.96%-newNEW
NOVO-NORDISK A S OPTNVO$7.5M100,0000.95%+0.51pp6q+586.0%+$6.4M
SELLAS LIFE SCIENCES GROUP I OPTSLS$7.4Moptions only0.93%+0.72pp5qOPTIONS
MODERNA INC OPTMRNA$7.0Moptions only0.88%-0.49pp2qOPTIONS
CORVUS PHARMACEUTICALS INC OPTCRVS$6.4M294,8110.81%-0.07pp4q+20.4%+$1.1M
MONTE ROSA THERAPEUTICS INC OPTGLUE$6.0M78,3910.76%+0.24pp3q-58.1%-$8.4M
ALUMIS INC OPTALMS$5.6Moptions only0.71%+0.22pp2qOPTIONS
ROYALTY PHARMA PLC OPTRPRX$5.6Moptions only0.71%-newOPTIONS
JOHNSON & JOHNSONJNJ$5.6M22,0000.71%-1.53pp3q-59.1%-$8.1M
UNICYCIVE THERAPEUTICS INC OPTUNCY$5.1M303,6760.65%+0.53pp2q+186.3%+$3.3M
CELLDEX THERAPEUTICS INC NEW OPTCLDX$5.1Moptions only0.64%-newOPTIONS
BIOHAVEN LTD OPTBHVN$4.7Moptions only0.60%+0.14pp3qOPTIONS
VERA THERAPEUTICS INC OPTVERA$4.6M57,6080.58%-newNEW
TENAX THERAPEUTICS INC OPTTENX$4.5Moptions only0.56%+0.08pp3qOPTIONS
RELAY THERAPEUTICS INCRLAY$4.3M230,6770.55%-newNEW
TG THERAPEUTICS INC OPTTGTX$4.2Moptions only0.53%-0.64pp7qOPTIONS
AMGEN INC OPTAMGN$3.8M102,7010.48%-newNEW
ZYMEWORKS INCZYME$3.7M142,1320.47%-0.14pp6qHELD
TAYSHA GENE THERAPIES INCTSHA$3.6M522,6190.45%-newNEW
INTELLIA THERAPEUTICS INC OPTNTLA$3.4Moptions only0.43%-0.01pp4qOPTIONS
NURIX THERAPEUTICS INCNRIX$2.9M121,5390.37%-newNEW
INDIVIOR PHARMACEUTICALS INCINDV$2.8M67,5120.35%-0.02pp2q-5.4%-$158.5K
INVENTIVA SAIVA$2.7M740,7860.34%+0.02pp3q+110.2%+$1.4M
ORUKA THERAPEUTICS INCORKA$2.6M27,7990.33%-newNEW
CYTOKINETICS INC OPTCYTK$2.6Moptions only0.32%-2.48pp2qOPTIONS
RELMADA THERAPEUTICS INCRLMD$2.5M361,3670.32%+0.08pp3q+79.9%+$1.1M
ANNEXON INC OPTANNX$2.2M27,5160.27%-0.18pp3q-79.3%-$8.3M
CELCUITY INC OPTCELC$2.1Moptions only0.26%-0.18pp2qOPTIONS
SEPTERNA INC OPTSEPN$2.0Moptions only0.25%+0.25pp2qOPTIONS
CYBIN INC OPTHELP$2.0M200,0000.25%-newNEW
VOYAGER THERAPEUTICS INC OPTVYGR$2.0M413,6420.25%-0.13pp2q-2.4%-$47.7K
CONTINEUM THERAPEUTICS INCCTNM$2.0M119,7330.25%-newNEW
BICYCLE THERAPEUTICS PLCBCYC$2.0M462,7240.25%-0.13pp2q-2.9%-$58.1K
VIRIDIAN THERAPEUTICS INCVRDN$1.8M100,0000.23%-newNEW
MACROGENICS INCMGNX$1.7M374,4030.22%-0.08pp2q-37.6%-$1.0M
PROQR THRAPEUTICS N VPRQR$1.7M926,0160.22%+0.17pp7q+414.2%+$1.4M
ADMA BIOLOGICS INC OPTADMA$1.7Moptions only0.21%-newOPTIONS
SPRUCE BIOSCIENCES INCSPRB$1.6M30,0000.20%+0.09pp2q+200.0%+$1.1M
ARDELYX INCARDX$1.5M303,0250.20%-newNEW
CUE BIOPHARMA INC OPTCUE$1.5M48,3690.19%-newNEW
MINERALYS THERAPEUTICS INCMLYS$1.5M56,3470.19%+0.07pp3q+113.9%+$809.4K
EYEPOINT INC OPTEYPT$1.5Moptions only0.19%-0.43pp2qOPTIONS
PROTHENA CORP PLCPRTA$1.5M149,4820.18%-newNEW
PHATHOM PHARMACEUTICALS INCPHAT$1.4M129,9500.18%+0.07pp2q+137.8%+$817.0K
EVOLUS INC OPTEOLS$1.4Moptions only0.18%+0.09pp3qOPTIONS
SPYRE THERAPEUTICS INCSYRE$1.3M15,0000.17%-newNEW
CORMEDIX INC OPTCRMD$1.3Moptions only0.17%-0.03pp4qOPTIONS
EDITAS MEDICINE INC OPTEDIT$1.3Moptions only0.16%-newOPTIONS
EQUILLIUM INCEQ$1.3M400,2820.16%+0.01pp4q-7.7%-$107.4K
PYXIS ONCOLOGY INC OPTPYXS$1.2Moptions only0.15%-newOPTIONS
XERIS BIOPHARMA HOLDINGS INCXERS$1.1M132,7460.13%flat4qHELD
PHARVARIS N VPHVS$1.0M29,3210.13%-0.01pp2qHELD
HARMONY BIOSCIENCES HLDGS INHRMY$978.1K26,8640.12%-0.32pp4q-71.1%-$2.4M
CARTESIAN THERAPEUTICS INCRNAC$907.1K87,0570.11%-newNEW
AQUESTIVE THERAPEUTICS INC OPTAQST$892.7Koptions only0.11%-newOPTIONS
RIGEL PHARMACEUTICALS INCRIGL$892.6K22,8160.11%-newNEW
ELICIO THERAPEUTICS INC OPTELTX$829.3Koptions only0.10%-newOPTIONS
PRECIGEN INCPGEN$771.2K135,2930.10%+0.06pp2q+144.7%+$456.0K
DEFINIUM THERAPEUTICS INCDFTX$726.8K15,4510.09%-newNEW
PELTHOS THERAPEUTICS INCPTHS$700.1K24,7730.09%flat4qHELD
PEPGEN INCPEPG$671.9K373,2840.08%+0.04pp2q+147.3%+$400.2K
CG ONCOLOGY INC OPTCGON$518.7Koptions only0.07%-newOPTIONS
ENLIVEN THERAPEUTICS INCELVN$507.5K10,0000.06%+0.06pp2q+3981.6%+$495.1K
CONNECT BIOPHARMA HLDGS LTDCNTB$468.8K196,9850.06%-0.03pp2q-1.8%-$8.8K
LARIMAR THERAPEUTICS INCLRMR$447.2K146,6370.06%-0.07pp2q-12.0%-$61.0K
CELLECTAR BIOSCIENCES INCCLRB$384.6K138,3410.05%-newNEW
FOGHORN THERAPEUTICS INCFHTX$326.5K66,9080.04%-0.02pp4q-16.3%-$63.6K
AYTU BIOPHARMA INCAYTU$319.4K148,5460.04%-0.12pp4q-57.9%-$439.7K
OCUGEN INCOCGN$306.0K200,0000.04%-0.12pp2qHELD
INOVIO PHARMACEUTICALS INC OPTINO$302.7Koptions only0.04%-0.15pp3qOPTIONS
UROGEN PHARMA LTDURGN$262.6K7,1370.03%-0.04pp7q-69.2%-$589.5K
HERON THERAPEUTICS INCHRTX$195.8K458,7230.02%-newNEW
TALPHERA INCTLPH$158.2K153,5630.02%flat3qHELD
MONOPAR THERAPEUTICS INCMNPR$150.9K1,6300.02%flat2qHELD
LAKELAND INDS INCLAKE$150.8K14,1080.02%-newNEW
UPSTREAM BIO INCUPB$132.1K19,0930.02%-0.02pp4q-11.6%-$17.4K
MEIRAGTX HLDGS PLC OPTMGTX$119.8K8,3680.02%-newNEW
JATT II ACQUISITION CORP$102.5K9,0210.01%-newNEW
KAILERA THERAPEUTICS INCKLRA$79.8K3,6210.01%-newNEW
MANNKIND CORPMNKD$68.2K16,0030.01%-0.07pp6q-91.4%-$726.8K
ENTERA BIO LTDENTX$41.2K23,2600.01%flat2qHELD
ARS PHARMACEUTICALS INCSPRY$38.9K4,8600.00%-newNEW
APREA THERAPEUTICS INCAPRE$36.0K44,9070.00%-newNEW
TVARDI THERAPEUTICS INCTVRD$31.6K16,6070.00%-newNEW
VISTAGEN THERAPEUTICS INC OPTVTGN$13.0Koptions only0.00%-0.01pp7qOPTIONS
NEXTCURE INCNXTC$12.4K7,7420.00%-newNEW
ATYR PHARMA INC OPTATYR$7.5Koptions only0.00%flat6qOPTIONS
JADE BIOSCIENCES INC OPTJBIO$3.2Koptions only0.00%flat4qOPTIONS
ERASCA INC OPTERAS$1.8Koptions only0.00%-newOPTIONS

By sector

Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.

Biotech & Pharma 95.6%Healthcare Services 2.0%Other sectors 0.0%Not classified 2.4%
 
SectorValueShare
Biotech & Pharma$756.7M95.6%
Healthcare Services$15.7M2.0%
Other sectors$150.8K0.0%
Not classified$18.8M2.4%

Quarter by quarter

QuarterValuePositions NewAddedTrimmed ExitedTop 10 Days to file
Q2 2026$791.3M1164321323850.4%45
Q1 2026$587.7M1114424195250.5%45
Q4 2025$580.5M1194616233349.4%48
Q3 2025$391.0M106536222239.1%45
Q2 2025$328.2M752316152053.7%45
Q1 2025$383.3M723117104567.5%45
Q4 2024$233.1M86000051.8%45

Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.

Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.

Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.